Daiwa Securities Group Inc. raised its stake in Clorox Company (The) (NYSE:CLX) by 44.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,200 shares of the company’s stock after buying an additional 1,600 shares during the period. Daiwa Securities Group Inc.’s holdings in Clorox Company (The) were worth $693,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of CLX. Korea Investment CORP increased its position in shares of Clorox Company (The) by 938.9% in the first quarter. Korea Investment CORP now owns 178,197 shares of the company’s stock valued at $24,026,000 after buying an additional 161,044 shares in the last quarter. Crossvault Capital Management LLC increased its position in shares of Clorox Company (The) by 3.8% in the first quarter. Crossvault Capital Management LLC now owns 34,684 shares of the company’s stock valued at $4,676,000 after buying an additional 1,285 shares in the last quarter. Ameriprise Financial Inc. increased its position in shares of Clorox Company (The) by 2.4% in the first quarter. Ameriprise Financial Inc. now owns 1,076,072 shares of the company’s stock valued at $146,932,000 after buying an additional 25,110 shares in the last quarter. Destination Wealth Management increased its position in shares of Clorox Company (The) by 14.0% in the first quarter. Destination Wealth Management now owns 30,225 shares of the company’s stock valued at $4,075,000 after buying an additional 3,716 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Clorox Company (The) by 4.3% in the first quarter. Geode Capital Management LLC now owns 1,247,940 shares of the company’s stock valued at $168,019,000 after buying an additional 51,563 shares in the last quarter. Institutional investors and hedge funds own 70.29% of the company’s stock.

Shares of Clorox Company (NYSE CLX) opened at 134.31 on Friday. The firm has a 50-day moving average price of $133.58 and a 200-day moving average price of $133.56. The firm has a market capitalization of $17.34 billion, a P/E ratio of 25.18 and a beta of 0.40. Clorox Company has a 52-week low of $111.24 and a 52-week high of $141.76.

Clorox Company (The) (NYSE:CLX) last released its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The business had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.65 billion. During the same period in the prior year, the firm earned $1.30 earnings per share. Clorox Company (The)’s revenue was up 2.9% compared to the same quarter last year. On average, equities research analysts anticipate that Clorox Company will post $5.67 EPS for the current year.

WARNING: This article was originally published by Daily Political and is owned by of Daily Political. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.dailypolitical.com/2017/08/13/daiwa-securities-group-inc-has-693000-stake-in-clorox-company-the-clx.html.

Several equities analysts have recently issued reports on CLX shares. Deutsche Bank AG reiterated a “hold” rating and set a $137.00 price objective (up from $126.00) on shares of Clorox Company (The) in a research report on Saturday, July 22nd. Vetr upgraded Clorox Company (The) from a “hold” rating to a “buy” rating and set a $139.67 price objective for the company in a research report on Monday, April 24th. Jefferies Group LLC started coverage on Clorox Company (The) in a research report on Tuesday, April 18th. They set a “hold” rating and a $138.00 price objective for the company. BMO Capital Markets reiterated a “buy” rating and set a $136.00 price objective on shares of Clorox Company (The) in a research report on Thursday, May 4th. Finally, Zacks Investment Research downgraded Clorox Company (The) from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company’s stock. Clorox Company (The) currently has a consensus rating of “Hold” and a consensus price target of $129.05.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.